Cooperative Agreement U01IP001269
Award Date
9/1/24
Completion Date
8/31/29
Dollars Obligated
$6M
Funding Federal Agency
National Center for Immunization and Respiratory Diseases
Awarding Federal Agency
Office of Financial Resources
Federal Grant Program
93.318
Assistance Type
Cooperative Agreement
Place of Performance
South Africa
Similar Awards
This $5,900,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) supports the National Health Laboratory Service (NHLS), a non-profit organization based in South Africa. The funding will be used to strengthen infectious disease surveillance, laboratory capabilities, and public health research over a 5-year period from September 2024 to September 2029. Key activities include establishing electronic case reporting...
This $6,300,000 Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program supports the South African National AIDS Council Trust (SANAC Trust) in coordinating, managing, monitoring, and engaging communities for the country's multi-sectoral HIV/AIDS response. The 5-year award, which runs from September 2024 to September 2029, aims to strengthen South Africa's capacity for national-level HIV/AIDS leadership, service...
The South African Medical Research Council (MRC) has been awarded a $4,968,390 cooperative agreement from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS federal grant program (CFDA 93.067) to strengthen strategic health information systems in South Africa. The award period is from September 30, 2024 to September 29, 2029. Through this cooperative agreement, MRC will work to enhance the collection, management, and use of data to support HIV/AIDS prevention,...
This $9,124,422 Cooperative Agreement award from the Centers for Disease Control and Prevention's Global AIDS (CFDA 93.067) program provides technical assistance and support to strengthen the government of Lesotho's national and district-level HIV and TB programming. The primary recipient, (Hisp) Health Information Systems Program South Africa, is a non-profit organization that specializes in developing and implementing sustainable digital health systems, with a focus on data management,...
This federal Cooperative Agreement award from the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) provides $11,097,080 to the Global Health Systems Solutions (GHSS) organization to build and improve integrated laboratory capacity and quality services in the Democratic Republic of the Congo (DRC) under the President's Emergency Plan for AIDS Relief (PEPFAR). The key objectives of this 5-year project include scaling up quality assurance and...
The Task Force for Global Health, Inc. was awarded a $2,475,519.00 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program. The award, with a performance period from August 1, 2024 to July 31, 2029, supports the Task Force's work in enhancing public health infrastructure for detecting, responding to, preventing, and controlling infectious diseases globally. Key activities...
This $684,241 cooperative agreement awarded by the Centers for Disease Control and Prevention (CDC) under the Emerging Infections Programs (CFDA 93.317) supports the New Hampshire Department of Health & Human Services' (NH DHHS) efforts to strengthen epidemiology and laboratory capacity for the prevention and control of emerging infectious diseases in the state. The award will enable NH DHHS to enhance infectious disease surveillance, outbreak response, data utilization, and collaboration...
The federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the Investigations and Technical Assistance program (CFDA 93.283), aims to advance diagnostic network optimization, stepwise laboratory accreditation, and integrated one health specimen transport in Liberia. The $1,770,000.00 award, with a performance period from September 30, 2024 to September 29, 2029, is granted to ICF Macro Inc., a subsidiary of ICF International, Inc. The...
This $8,295,059 cooperative agreement, awarded by the Centers for Disease Control and Prevention (CDC) under the Global AIDS (CFDA 93.067) program, provides funding to the Republic of Namibia Ministry of Health and Social Services (MOHSS) to support HIV prevention, testing, treatment, and care services in Namibia. The 5-year project, spanning from September 30, 2024 to September 30, 2029, aims to strengthen the national health system, expand access to antiretroviral therapy, improve laboratory...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $25,300,000 Cooperative Agreement under the Global AIDS (CFDA 93.067) federal grant program to Ciheb Initiative LIMITED in Malawi. The 5-year award, effective September 30, 2024, will support the "ACCELERATING MALAWI'S PEPFAR LABORATORY LOGISTICS AND INFRASTRUCTURE FOR QUALITY 2.0 (AMPLIFY 2.0)" project. The project aims to strengthen Malawi's national health system by improving laboratory logistics and...